发明名称 |
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
摘要 |
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal. |
申请公布号 |
US9062103(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US201414250807 |
申请日期 |
2014.04.11 |
申请人 |
The Texas A&M University System;Temple Therapeutics, Inc.;Scott & White Healthcare |
发明人 |
Prockop Darwin J.;Oh Joo Youn;Berkowitz Barry;Roddy Gavin W.;Rosa Robert |
分类号 |
A61K38/00;A61P27/02;C07K16/18;A61K9/00;A61K35/28;C12N5/0775;A61K35/12 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
Lillie Raymond J. |
主权项 |
1. A method of treating dry eye syndrome in a patient, comprising:
administering to said patient a therapeutic agent comprising TSG-6 protein or a biologically active fragment, or variant thereof, wherein said TSG-6 protein or biologically active fragment, or variant thereof, is administered in an amount effective to treat said dry eye syndrome in said patient. |
地址 |
College Station TX US |